Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

作者： Hui-Ching Hsu1, Ming-Feng Liao2, Jung-Lung Hsu2, Yun-Lin Lee2, Long-Sun Ro2 1Department of Traditional Chinese Medicine, Division of Chinese Acupuncture and Traumatology,Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine, 2Department of Neurology,Chang Gung Memorial Hospital Linkou Medical Center and Chang Gung University College of Medicine

简介：

Overview

This article presents a protocol for confirming point mutations in hereditary transthyretin amyloidosis, specifically using the Ala97Ser mutation prevalent in Taiwan. The method is designed to be straightforward and applicable in clinical laboratories.

Key Study Components

Area of Science

• Genetics
• Clinical Diagnostics
• Neurobiology

Background

• Transthyretin amyloidosis is a condition with significant clinical implications.
• Early diagnosis can improve patient outcomes.
• Point mutations play a crucial role in the disease's pathology.
• The Ala97Ser mutation is the most common in Taiwan.

Purpose of Study

• To establish a reliable protocol for detecting point mutations.
• To facilitate early diagnosis of hereditary transthyretin amyloidosis.
• To improve the understanding of genetic variants associated with the disease.

Methods Used

• DNA extraction from blood samples.
• PCR amplification of target regions.
• Agarose gel electrophoresis for DNA visualization.
• Sequencing to confirm mutations.

Main Results

• Successful amplification of the TTR gene region.
• Identification of the Ala97Ser mutation in affected individuals.
• Clear visualization of PCR products on agarose gel.
• Demonstration of the protocol's feasibility in clinical settings.

Conclusions

• The protocol is effective for diagnosing hereditary transthyretin amyloidosis.
• It can be implemented in routine clinical practice.
• Early detection of mutations can lead to better patient management.

Frequently Asked Questions